1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>South Korea

Invossa Fallout: Call For Review Of All Korea-Approved Cell Therapies

 
• By Jung Won Shin

Although the big decision has been made for Invossa in Korea, things have not settled down and there have been calls for re-examination of all approved cell therapies, the recall of R&D grants provided to Kolon and expansion of a probe into the company’s leadership and government officials.

Storm
Invossa Fallout Might Spread To Other Cell Therapies • Source: Shutterstock

Following the shocking withdrawal of approval in South Korea of Kolon Life Science Inc.’s cell and gene therapy Invossa (TG-C), a local pharmacist organization has questioned whether the problems relate only to Invossa and has urged the government to launch a full-scale re-examination of all 16 cell therapies approved in the country.

The Invossa incident has revealed the Ministry of Food and Drug Safety’s (MFDS) weak management of cell and gene therapies, so “we have to raise the most important question

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Asia